Veterans lawsuit. Rollout disruption. Settlement era. Times Square flagship.

One of the most consequential legal challenges to New York’s rollout came from a group of service-disabled veterans who argued they had been improperly excluded from the state’s licensing framework.

When New York launched its adult-use cannabis market, the rollout was framed around social equity. The promise was that individuals harmed by cannabis prohibition, justice-involved applicants, and communities disproportionately impacted by enforcement would finally have an opportunity to participate in a newly legal industry.

The lawsuit became one of the defining controversies of New York cannabis, with supporters viewing it as a fight for inclusion and critics arguing it disrupted opportunities for social equity applicants already attempting to enter the market.

One of those plaintiffs was William Norgard.

Years later, public records would connect Norgard to 2 Forest Park Lane LLC, the licensed entity behind The Daily Green, a flagship dispensary occupying some of the most valuable cannabis real estate in the country.

The sequence is difficult to ignore.

A plaintiff in litigation that significantly altered the trajectory of New York’s cannabis rollout later emerges connected to a premier Times Square cannabis operation.

As Cannabrite followed the public record, additional names surfaced.

Public reporting identifies attorney and hospitality entrepreneur James Mallios as a partner in the project. Reporting surrounding the property itself introduces additional real-estate and investment interests connected to the Times Square location.

One detail from Norgard’s own public statements adds another layer to the story.

In an interview with Task & Purpose, Norgard stated that he is “neither a proselytizer nor an advocate for cannabis.” He explained that he qualified for a cannabis license as a service-disabled veteran under New York law and received that license through the settlement that resolved the veterans’ lawsuit against New York State.

Norgard also stated that he owns 51% of the Times Square dispensary, is not the sole owner, and does not participate in hiring, firing, inventory management, or other day-to-day operations of the business.

Those statements stand in contrast to the broader public conversation that surrounded New York’s legalization effort.

For years, the discussion centered on social equity, justice-involved applicants, legacy operators, and individuals who had spent decades advocating for cannabis reform. The market was frequently presented as an opportunity to create pathways for those communities to participate in a newly legal industry.

Yet one of the most visible outcomes of the rollout is a Times Square flagship connected to a plaintiff who openly states he is not a cannabis advocate and who received his license through the settlement of one of the lawsuits that helped reshape the market itself.

None of these facts establish wrongdoing.

But they do raise questions about how power, capital, access, and opportunity move through an emerging industry.

While filings identify 2 Forest Park Lane LLC as the licensed entity and publicly connect Norgard to the project, the complete ownership structure, financing arrangements, and equity relationships behind the operation are not fully disclosed in publicly available records reviewed by Cannabrite.

The location itself has its own history.

Before operating as The Daily Green, the Times Square dispensary was known as Charlie Fox, one of New York’s most visible early adult-use cannabis retailers. Public reporting indicates the location was later rebranded as The Daily Green following a change in ownership and management structure.

But perhaps the most interesting question isn’t who owns The Daily Green.

Perhaps the more important question is what this timeline reveals about New York cannabis itself.

The timeline raises questions about how New York’s cannabis market evolved from its original social-equity vision.

A plaintiff in one of the most consequential lawsuits in the history of the state’s cannabis rollout later emerged connected to one of the most prominent dispensary projects in New York.

Veterans lawsuit → settlement → Norgard → Times Square flagship

That is not an allegation. It is a matter of public record.

Whether readers view that outcome as a success story, a coincidence, a product of perseverance, or an example of how influence and opportunity intersect within emerging industries is ultimately up to them.

What cannot be disputed is the sequence of events. Veterans lawsuit. Rollout disruption. Settlement era. Times Square flagship.

The public record connects each chapter.

In New York cannabis, the most important stories are rarely about what happens behind the counter. They are about what happens long before the doors open. The public record tells us where the story began and where it ended. The question for readers is what happened in between.

The individuals and entities referenced in this article have not been accused of wrongdoing. Cannabrite welcomes comment, clarification, or additional context from any party mentioned and will update this article accordingly.